Tag Archives: VTGN

Best Medical Stocks To Invest In 2023

What happened

Wednesday was a hump day to forget for specialty medical device maker Conformis (NASDAQ:CFMS). Investors weren’t happy with a guidance cut from the company, and expressed their displeasure by trading its shares down by 10.6%.

So what

Conformis, which specializes in products used in hip replacement procedures, revealed in a business update that it expects less product revenue than previously anticipated for its current third quarter. The new expectation is for a top-line result of $13.7 million to $14.3 million. That’s notably below the preceding....More>>>

Top 10 Clean Energy Stocks To Buy Right Now

Shah Gilani

Every week, I publish a “watchlist” of stocks for my Total Wealth free e-letter subscribers. It’s just like how it sounds; they’re stocks I’m keeping tabs on because I see the potential for big, imminent moves. That’s also why I talk about speculative trades people can execute to cash in on those moves.

My editor, though, asked me to share this week’s watchlist with everybody because it’s packed with clean energy stocks.

Thanks to the infrastructure bill, and what will likely be billions and billions in earmarks,....More>>>

Top 10 Casino Stocks To Watch For 2019

Michael E. Lewitt

Back in April, I recommended Caesars Entertainment Corp. (Nasdaq: CZR) as a buy – but warned you that this was a play that might take some time to mature.

If you haven’t gotten in already, you’ll want to do it soon.

After months of bitter wrangling, the much-beleaguered Caesars has finally reached a $5 billion deal with the private-equity sponsors that looted the company, Apollo Global Management, LLC (NYSE: APO) and TPG Capital (formerly Texas Pacific Group). Pending approval by the U.S. Bankruptcy Court in Chicago, CZR is....More>>>

Top 10 Blue Chip Stocks To Watch Right Now

Dividend growth investing can be a great way to boost your passive income over time. To do it right, though, you have to find stocks that can both grow their dividends faster than inflation and have sustainable free cash flows for the long haul.

Gilead Sciences (NASDAQ:GILD), a blue chip biotech stock, meets both of these critical criteria. Even so, this top biotech is rarely considered purely for its prospects as a dividend growth stock. The reason? Gilead only started doling out a dividend approximately three years ago this month. As a result, the company has yet to shed its well-earned....More>>>

Top 5 Low Price Stocks To Invest In Right Now

Analysis focus: RARE

Ultragenyx (NASDAQ:RARE), which we recommended as a buy in October 2017 when it was trading at 52-week lows, has been up 50% since our recommendation. We recommended it on the basis of an upcoming approval of its Sly syndrome treatment MEPSEVII in November – which happened; and another approval of borosumab (Crysvita) in April – which also happened. We also liked its cash position, both then and now, and its sale of a Rare Disease Priority Review voucher for $130mn. We didn’t like its two trial failures from before, and its overpaid purchase of another....More>>>